For the Inventor, By the Inventor

Enter inventor name

Piero Foresta

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Rome, IT (1989 - 2001)
Pomezia, IT (1993 - 2006)

Company Filing History:

Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Inverni Della Beffa Industria Chimico Farmeceutica Derivati Naturali

where one patent can have more than one assignee

Years Active: 1989-2006

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7041703 - 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies (2006-05-09),

2. 6849663 - 2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies (2005-02-01),

3. 6242497 - Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies (2001-06-05),

4. 6225501 - Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock (2001-05-01),

5. 6180667 - Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock (2001-01-30),

6. 5962525 - 6,7-disubstituted-2-aminotetralines active as immunomodulators and (1999-10-05),

7. 5814661 - Use of Phthalidyliden esters of carnitine and alkanoyl carnitines for (1998-09-29),

8. 5637614 - 6,7-disubstituted-2-aminotetralines and pharmaceutical compositions (1997-06-10),

9. 5625085 - Esters of acyl L-carnitines and pharmaceutical compositons containing (1997-04-29),

10. 5591777 - Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical (1997-01-07),

11. 5525627 - Esters of acyl carnitines with long-chain aliphatic alcohols and (1996-06-11),

12. 5519056 - Esters of acyl carnitines with long-chain aliphatic alcohols and (1996-05-21),

13. 5498633 - Esters of acyl carnitines with long-chain aliphatic alcohols and (1996-03-12),

14. 5498632 - Esters of acyl carnitines with long-chain aliphatic alcohols and (1996-03-12),

15. 5298621 - Oligopeptide derivatives of ipoxantine endowed with immunomodulating (1994-03-29),

Title: Piero Foresta: Innovator in Pharmaceutical Compositions

Introduction

Piero Foresta is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for inflammatory and autoimmune pathologies. With a total of 17 patents to his name, Foresta's work has had a considerable impact on medical science.

Latest Patents

Foresta's latest patents focus on 2-aminotetralines and their pharmaceutical compositions. These innovations are aimed at the prevention and therapeutic treatment of inflammatory conditions, especially septic shock and autoimmune diseases. His patents detail a process for the preparation of 2-aminotetralines, emphasizing their role in addressing the aetiopathogenic effects of inflammatory cytokines.

Career Highlights

Throughout his career, Piero Foresta has worked with prominent companies in the pharmaceutical industry, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Sigma-Tau. His expertise in pharmaceutical compositions has positioned him as a key figure in the development of innovative treatments.

Collaborations

Foresta has collaborated with notable professionals in his field, including Maria Ornella Tinti and Vito Ulderico Ruggiero. These partnerships have further enhanced his research and development efforts.

Conclusion

Piero Foresta's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical treatments for inflammatory and autoimmune diseases. His work continues to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…